To confirm the findings obtained in genetically modified mice, we used the TRPC4/5 antagonist, ML204.11 ML204 or vehicle was administered 1 h prior to induction of arthritis and daily thereafter (see online supplementary figure S3A). The gene discussed is TRPC4; the disease is arthritic joint disease.